Established in 2011, Fast Track Pharma is a pharmaceutical business combining innovation with fast, low cost development and early value realisation.
The Company is headquartered in the UK but has already established strong business links internationally, particularly in Europe, USA and Canada.
With a clinical focus in gender health and pain, the Company applies the founders’ extensive experience in product development, clinical strategic marketing and regulatory affairs to generate revenues by;
- Gaining approval and then marketing distributed products in Europe.
- Establishing new intellectual property to improve the performance of existing, generic drugs in their approved indications for the treatment of gender health and pain. This new intellectual property will be licensed to pharmaceutical partners either on a global basis or territorially after completion of rapidly executed proof of concept studies.
It has a novel financial model which delivers early dividend returns to shareholders.